(VIANEWS) – The NASDAQ ended the session with Inovio Pharmaceuticals jumping 4.12% to $4.80 on Friday, after two successive sessions in a row of losses. NASDAQ Composite rose 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat up trend exchanging session today.


Today’s last reported volume for Inovio Pharmaceuticals is 3705370, 14.27% below its average volume of 4322310.

Inovio Pharmaceuticals’s last close was $4.61, 75.74% below its 52-week high of $19.00.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is 311% for the current quarter and 132.2% for the next. The company’s growth estimates for the present quarter and the next is a negative 400% and a negative 121.4%, respectively.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 6.52M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Inovio Pharmaceuticals’s stock is considered to be overbought (>=80).

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $4.80 at 16:05 EST, way below its 52-week low of $5.75.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s worth is way under its 50-day moving average of $6.91 and way below its 200-day moving average of $8.05.

More news about Inovio Pharmaceuticals (INO).


Please enter your comment!
Please enter your name here